Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jingyi Shen
Institution:
First Hospital of China Medical University
Observed institutions:
Pitzer College,
Xuzhou Medical College,
Affiliated Hospital of Xuzhou Medical College,
First Hospital of China Medical University,
China Medical University
ORCID:
0009-0003-8677-4823
Observed ORCID:
0009-0003-8677-4823
OpenAlex ID:
A5112722152
Thymus Degeneration and Regeneration
2021
·
Maxwell Duah
, Lingling Li
, et al.
·
Frontiers in Immunology
·
75
PDF
Proteasome β5 subunit overexpression improves proteostasis during aging and extends lifespan in Drosophila melanogaster
2019
·
Nga N. Nguyen
, Anil Rana
, et al.
·
Scientific Reports
·
74
PDF
Blockade of PD-1/PD-L1 increases effector T cells and aggravates murine chronic graft-versus-host disease
2022
·
Yiwen Liang
, Jingyi Shen
, et al.
·
International Immunopharmacology
·
10
Inhibition of IL-1 Receptor-Associated Kinase 1 Decreases Murine Acute Graft-versus-Host Disease While Preserving the Graft-versus-Lymphoma Effect
2021
·
Jun Gao
, Yan Xu
, et al.
·
Transplantation and Cellular Therapy
·
7
A Prospective Clinical Trial of Efgartigimod for New-Onset Generalized Myasthenia Gravis
2025
·
Chi Ma
, Jingyi Shen
, et al.
·
Current Neuropharmacology
·
5
PDF
Efgartigimod in Very-Late-Onset Generalized Myasthenia Gravis: A Real-World Study on Effectiveness and Safety
2026
·
Chi Ma
, Jingyi Shen
, et al.
·
Current Neuropharmacology
·
3
PDF
Thrombin receptor activating peptide-6 decreases acute graft-versus-host disease through activating GPR15
2024
·
Cong Liu
, Qiu Lan
, et al.
·
Leukemia
·
3
Development and Validation of a Nomogram to Predict Minimal Symptom Expression in AChR+ gMG Patients Undergoing Efgartigimod Therapy
2026
·
Chi Ma
, Nan Kang
, et al.
·
Current Neuropharmacology
Show more works
View as search
Works count:
8
Citation count:
177
H-index:
5
I10-index:
3
Year
Topic
Type